Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy in Inoperable Thoracic Esophageal Cancer
NCT02403531Phase 2Completed
- Sponsor
- Mianxi Biopharma
- Start
- May 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Mianxi Biopharma. Started May 2015; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02403531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403531.